Evidence map›Paper›PMID 30880301›Full record

ArticleInternal medicine (Tokyo, Japan)2019

Recurrent Epstein-Barr Virus-positive (EBV+) Primary Central Nervous System Lymphoma (PCNSL) in a Patient with Clinical Features of Chronic Lymphocytic Inflammation with Pontine Perivascular Enhancement Responsive to Steroids (CLIPPERS).

Masahiro Nagano, Takashi Ayaki, Natsuko Koita, Toshiyuki Kitano, Momoko Nishikori, Naoki Goda, Sachiko Minamiguchi, Akio Ikeda, Akifumi Takaori-Kondo, Ryosuke Takahashi

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Inflammatory brain lesions preceding primary central nervous system lymphoma: a case report and genetic analysis.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2023
    Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Masahiro NaganoDepartment of Neurology, Kyoto University Graduate School of Medicine, Japan.
Takashi AyakiDepartment of Neurology, Kyoto University Graduate School of Medicine, Japan.
Natsuko KoitaDepartment of Neurology, Kyoto University Graduate School of Medicine, Japan.
Toshiyuki KitanoDepartment of Hematology and Oncology, Kyoto University Graduate School of Medicine, Japan.
Momoko NishikoriDepartment of Hematology and Oncology, Kyoto University Graduate School of Medicine, Japan.
Naoki GodaDepartment of Diagnostic Pathology, Kyoto University Graduate School of Medicine, Japan.
Sachiko MinamiguchiDepartment of Diagnostic Pathology, Kyoto University Graduate School of Medicine, Japan.
Akio IkedaDepartment of Neurology, Kyoto University Graduate School of Medicine, Japan.
Akifumi Takaori-KondoDepartment of Hematology and Oncology, Kyoto University Graduate School of Medicine, Japan.
Ryosuke TakahashiDepartment of Neurology, Kyoto University Graduate School of Medicine, Japan.
Kyoto University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary central nervous system lymphoma (PCNSL) and chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS) can share clinical features and may be indistinguishable, even after brain biopsy. We encountered a case of Epstein-Barr virus-positive (EBV+) PCNSL recurrence in a patient with clinical features of CLIPPERS, and repeat brain biopsy was required to reach the correct diagnosis. Four years after the initial diagnosis and treatment of PCNSL, "peppering" punctate enhanced lesions with transient steroid responsiveness were detected during brain magnetic resonance imaging (MRI). A second brain biopsy supported a diagnosis of CLIPPERS, while a third biopsy confirmed the diagnosis of recurrent PCNSL.

Indexed as

AdultAntineoplastic AgentsBrain Stem NeoplasmsCentral Nervous System NeoplasmsChronic DiseaseHerpesvirus 4, HumanHumansInflammationLymphocytesLymphomaMaleMethylprednisoloneNeoplasm Recurrence, LocalTreatment OutcomeAntineoplastic AgentsMethylprednisolonechronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS)Epstein-Barr virus (EBV)primary central nervous system lymphoma (PCNSL)recurrencerepeat brain biopsy

Identifiers

PMID30880301
PMCPMC6465023
OpenAlexW2921796174

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.